Clinical Trial Update: Phase 3 Study of Surgery Combined With Neoadjuvant Chemotherapy(XELOX) in Colorectal Cancer With Resectable Liver Metastasis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating surgery with neoadjuvant XELOX chemotherapy for colorectal cancer with resectable liver metastases; current study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Colorectal Cancer with Liver Metastases

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Colorectal Cancer, Resectable Liver Metastasis | Phase 3 | Status: UNKNOWN